急性髓性白血病在青少年异常性关节炎的免疫抑制疗法期间通过骨髓扩散特征发展
Masahiro Oura1, Ryohei Sumitani1, Yusaku Maeda1
1Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
一名青少年异常性关节炎患者在免疫抑制疗法期间发展出骨髓质疏松综合征/骨髓扩散性瘤,不可分类 (MDS/MPN-U) 和急性骨髓性白血病. 迅速治疗导致完全缓解,突出显示了JIA患者的恶性瘤风险.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 类风湿病学 类风湿病学
背景情况:
- 青春期异常性关节炎 (JIA) 需要免疫抑制疗法,这可能会带来风险.
- 在患有慢性炎症疾病的患者中,对二次恶性瘤的监测至关重要.
研究的目的:
- 报告一个罕见的MDS/MPN-U病例和随后的AML病例,该病例发生在接受免疫抑制剂治疗的JIA患者中.
- 强调在JIA治疗期间考虑恶性瘤的发展的重要性.
主要方法:
- 一个17岁的男性患有JIA的案例报告.
- 骨髓检查用于诊断MDS/MPN-U.
- 用托西利祖马布 (tocilizumab),普雷迪尼索隆 (prednisolone),甲铁酸 (methotrexate) 治疗,然后进行干细胞移植和化疗.
主要成果:
- 患者出现了血栓细胞形成和关节痛恶化.
- 骨髓检查显示MDS/MPN-U,进展为急性髓性白血病.
- 在干细胞移植和化疗后实现了完全缓解.
结论:
- 强化免疫抑制疗法可能与JIA患者血液恶性瘤的发展有关.
- 早期诊断和积极的治疗,包括干细胞移植,对于管理这些并发症至关重要.
- 在经历长期免疫抑制的JIA患者中,对二次恶性瘤的密切监测至关重要.
更多相关视频
10:10Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
